Core A: Molecular Imaging Reporter Core (MIRC)
Core A: Molecular Imaging Reporter Core (MIRC)
批准号:
7287034
负责人:
David Piwnica-Worms
金额:
$27.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-28 至 2011-12-31
关键词:
Animal ExperimentationAnimalsArchivesBiologicalBioluminescenceBreedingCancer BiologyCatalogingCatalogsCell LineCellsCellular biologyChimeric ProteinsCloningCloning VectorsCollectionCommunitiesComputer softwareCore FacilityCulture MediaCultured CellsDatabasesDate of birthDoctor of PhilosophyEngineered GeneEngineeringEnvironmentEquipment and supply inventoriesExperimental DesignsFirefly LuciferasesFluorescenceFreezingGene ExpressionGene Expression RegulationGenerationsGenetic TransductionImageInstitutionJournalsKnock-in MouseLabelLeftLigandsLinkLiteratureLuciferasesMammalian CellMapsMichiganModalityMolecularMolecular BiologyMusNumbersOnline SystemsOrder ColeopteraParentsPilot ProjectsPlasmidsPositioning AttributePositron-Emission TomographyProductionProgress ReportsProtein FragmentProteinsProtocols documentationPublicationsPublished CommentRadioRangeReagentRecordsRenilla LuciferasesReporterReporter GenesReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesScientistServicesSignal PathwaySiteSourceSpecialized CenterStandards of Weights and MeasuresSystemTNFRSF5 geneTimeTrainingTransgenesTransgenic AnimalsTransgenic OrganismsUbiquitinUniversitiesVertebral columnVial deviceVirusWashingtonXenograft procedureanaloganimal carebasecoelenterazinedesigndissemination researchestablished cell lineexperienceexpression cloningin vitro Assayin vivoin vivo Cellular and Molecular Imaging Centersinnovationinterestmolecular imagingmulticatalytic endopeptidase complexmutantnovelprogramspromoterprotein protein interactionrepositoryresearch studysexvectoryeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A.3.I. Molecular Imaging Reporter Core (MIRC)
The Molecular Imaging Reporter Core is a central facility providing expertise, materials and
collaborative assistance for design and execution of biological aspects of molecular imaging. If one was to
identify the one Core that represented the essence of ICMIC innovation at Washington University, it would
be the Molecular Imaging Reporter Core. The MIRC serves investigators possessing a wide range of
resources and experience in molecular biology, cell culture, and animal experimentation. One of the most
important activities of this core is discovery research and dissemination of our novel molecular imaging
reagents and genetically-encoded reporters to investigators within our institution, to other P50 program sites
and to cancer biology and imaging investigators throughout the world. Discovery research in this Core
provided the research community with: 1) Novel PET- and bioluminescence-based reporters of proteinprotein
interactions in vivo based on modified two-hybrid transcriptional strategies, 2) Novel firefly luciferase
protein fragment complementation strategies for real-time imaging of protein-protein interactions in vivo, 3)
Novel fusion protein strategies for imaging proteasome function in vivo, 4) Innovative platform strategies to
interrogate ubiquitin-induced degradation of ligand-regulated proteins in signaling pathways in real time
(e.g., kB, p-catenin and Cdc25A), 5) Second generation fusion reporters and triple-modality reporters for
multi-modality imaging (PET/bioluminescence/ fluorescence), 6) Engineered convenient vectors for cloning
and expression of click beetle luciferases, firefly luciferase, Renilla luciferase, mtHSV1-TK, mtSSTR-2 and
others for a variety of imaging applications, and 7) Production of transgenic and knock-in molecular imaging
reporter mice (e.g., Gal4-Fluc, p21-Fluc, ROSA26-LSL-CGR-mGFP).
Indeed, this Core has been and continues to be one of our most productive and
comprehensive activities, discovering and developing novel reporters and impacting a broad range
of research programs throughout the world. Many investigators within the Washington University
community as well as outside institutions have directly received material and support from the WU MIRC
during the 5 year period covered by the progress report. These activities include new initiatives,
continuation collaborative projects as well as pilot projects that now extend our reach far beyond the focus
of the original projects proposed for the Center Program. Overall, as of June 2006, we have distributed our
collection of molecular imaging reporter reagents and cells to dozens of WU investigators as well as 86
investigators throughout the world. Several other P50 ICMIC institutions have requested and received our
cells and reagents, including investigators at the Johns Hopkins University ICMIC (split firefly luciferase,
Ub-FLuc plasmid, IkB-FLuc and control plasmids); investigators at the Stanford University ICMIC (IkB-FLuc,
FLuc vectors, stable reporter cells expressing IkB-FLuc, coelenterazine analogues); investigators at the
University of Michigan ICMIC (split firefly luciferase, Ub-FLuc plasmid); and investigators at Harvard (split
firefly luciferase, IkB-FLuc). Our most popular reagents (implying high impact) include plasmids encoding
our luciferase complementation fragments (split luciferase), IkB-firefly luciferase fusion construct, polyubiquitinated-
firefly luciferase, mutant NLS-sr39HSV1-TK-EGFP fusion reporter, and Gal4-firefly luciferase
reporter. Publications in high profile journals (e.g., PNAS 2006, 103:1313-1318) have already appeared in
the literature citing us as the source of these molecular imaging reagents for their respective projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
First-in-Human Imaging of Innate Immunity Activation with a Redox-Tuned PET Reporter
-
批准号:10577531
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2023
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging Core
-
批准号:10517142
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2022
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging Core
-
批准号:10707122
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2022
-
负责人:David Piwnica-Worms
-
依托单位:
Administrative Core
-
批准号:8658378
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2014
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging Reporter
-
批准号:8195499
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging High Throughtput Screening
-
批准号:8195501
-
项目类别:
-
资助金额:$6.35万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Imaging and Characterizating Stress responses in vivo with p21 Reporter Mice
-
批准号:8195496
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Administrative Core
-
批准号:8195493
-
项目类别:
-
资助金额:$66.14万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
PET Imaging of GVHD and GVL after treatment with Azacitidine
-
批准号:8195498
-
项目类别:
-
资助金额:$11.47万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Administration
-
批准号:7287029
-
项目类别:
-
资助金额:$35.19万
-
财政年份:2007
-
负责人:David Piwnica-Worms
-
依托单位:
Soc for Molecular Imaging 3rd Annual International Mtg
-
批准号:6877284
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2004
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:6620939
-
项目类别:
-
资助金额:$183.3万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7795900
-
项目类别:
-
资助金额:$196.12万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7278495
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7498493
-
项目类别:
-
资助金额:$159.63万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:8181436
-
项目类别:
-
资助金额:$142.89万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:8101135
-
项目类别:
-
资助金额:$176.51万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:6712737
-
项目类别:
-
资助金额:$220.1万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:6667006
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7026447
-
项目类别:
-
资助金额:$204.26万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
海外基金